The coronavirus storm, first reported more than a year ago, has overshadowed all societies' parts and become a chal-lenge to all of the world's health systems 1. Extremely high contagiousness, significant mortality rates, and the lack of a de-finitive cure have prioritized overcoming this outbreak. In this regard, studies related to coronavirus and especially its clini-cal studies, became a priority for researchers and decision-makers at the request of governments and the people, as well as by the logic. The superiority of an emergency is not a wrong decision. Still, the problem arose when other research areas were neglected, and their budgets were reduced by decision-makers, resulting in damage to the research and researchers in other fields 2, 3. The clinical studies currently being conducted on coronavirus disease 2019 (COVID-19) are due to previous studies in the basic sciences that have provided the background. Obviously, without scientists' tasks over the years and the allocation of research funds to the fields of genetics, biochemistry, immunology, etc., studies and advances would not be possible today